Transaction in Own Shares

Summary by AI BETAClose X

Ryanair Holdings plc announced that between August 10 and August 14, 2026, it repurchased 193,778 ordinary shares at an average price of approximately €24.80 and 82,290 ordinary shares underlying American Depositary Shares at an average price of approximately US$29.75, all for cancellation as part of its ongoing share buy-back program.

Disclaimer*

Ryanair Holdings PLC
17 August 2026
 

Ryanair Holdings plc

Transactions in own shares

Ryanair Holdings plc (the "Company") announces that in the period 10 August 2026 to 14 August 2026 it purchased for cancellation in aggregate 193,778 ordinary shares of nominal value €0.006 each in the capital of the Company ("Ordinary Shares") and in aggregate 82,290 Ordinary Shares underlying the American Depositary Shares, as further detailed below.

Date

Number of Ordinary Shares

Volume weighted average price paid

Number of Ordinary Shares underlying American Depositary Shares

Volume weighted average price paid

10 August 2026

38,521

24.8623

16,546

US $29.8817

11 August 2026

38,652

24.6896

17,162

US $29.7487

12 August 2026

38,931

25.0531

16,242

US $29.8594

13 August 2026

38,644

24.9967

16,116

US $29.7085

14 August 2026

39,030

24.5601

16,224

US $29.4139

 

These share purchases form part of the Company's existing share buy-back programme, details of which were announced on 20 May 2025 (the "Programme").  Purchases made under the share buyback programme will be announced on a weekly basis.

 

All shares purchased by the Company will be cancelled. This announcement is being made in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended. 

Issuer name:


Ryanair Holdings plc


LEI


635400BR2ROC1FVEBQ56

ISIN:


IE00BYTBXV33

 

Enquiries:

Contact:

Jamie Donovan

Ryanair Holdings Plc

Tel: + 353 1 945 1212

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings